Phototherapy services for newborns with jaundice: Availability and practices in Southeast Nigeria

Submitted: 25 September 2022
Accepted: 24 November 2022
Published: 29 December 2022
Abstract Views: 250
PDF: 130
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Severe neonatal hyperbilirubinemia remains a cause of neurologic damage in children in low-income countries. Phototherapy, which is the standard of care for neonatal hyperbilirubinemia is not only necessary but an essential neonatal service that should be readily available in all health facilities with maternal and newborn services. The study describes the availability and distribution of phototherapy service in secondary health facilities in Southeast Nigeria. This was a cross-sectional descriptive study carried out in four of the largest cities in Southeast Nigeria using purposive and convenient sampling methods. A questionnaire was administered and information regarding the availability of phototherapy machines, its use and availability of personnel was obtained. A total of 77 facilities were surveyed. Fifty-five (71.4%) of the studied facilities manage jaundice in their facility. Of these, 45/55 (81.8%) use phototherapy in the management of jaundice in newborns. The most used phototherapy is Light-Emitting Diode (LED) (42.2%). Others were fluorescent (26.6%), fabricated LED (11.1%) and fabricated fluorescent (20%). Routine serum bilirubin assay was done in 60 (77.9%) facilities even though majority was done in laboratories outside the facility. Non-invasive serum bilirubin monitoring was available in only two facilities. Only 21 (47.7%) had a servicing protocol for their phototherapy machines, and just 12 (27.7%) of these services were offered by a biomedical engineer. Phototherapy use in secondary health facilities is suboptimal. There is urgent need for states health authorities to collaborate with private health facilities especially those offering maternal and child services in provision of phototherapy machines and help in the training health workers for optimal management of neonatal hyperbilirubinemia.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117–71. DOI: https://doi.org/10.1016/S0140-6736(14)61682-2
Kamath BD, Thilo EH, Hernandez JA. Jaundice. In : Gardner SL, Carter BS, Enzman – Hines M, Hernandez JA, eds. Merenstein and Gardner’s handbook of intensive neonatal care. Missouri, USA: Mosby Elsevier Inc. 2011:531-52.
Bhutani VK, Johnson L. A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J Perinatol 2009;29:S61-7. DOI: https://doi.org/10.1038/jp.2008.213
Owa JA, Osinaike AI. Neonatal morbidity and mortality in Nigeria. Indian J Pediatr 1998; 65:441-9. DOI: https://doi.org/10.1007/BF02761140
Okechukwu AA, Achonwa A. Morbidity and mortality patterns of admissions into the Special Care Baby Unit of University of Abuja Teaching Hospital, Gwagwalada, Nigeria. Niger J Clin Pract 2009;12:389–94.
Toma BO, Ige OO, Abok II, et al. Pattern of neonatal admissions and outcome in a tertiary institution in North Central Nigeria. J Med Trop 2013;15:121‑5. DOI: https://doi.org/10.4103/2276-7096.123590
Onyearugha CN, Onyire BN, Ugboma HAA. Neonatal jaundice: Prevalence and associated factors as seen in Federal Medical Centre Abakaliki, Southeast Nigeria. J Clin Med Res 2011;3:40-5.
Ogunlesi TA, Dedeke IO, Adekanmi AF, et al. The incidence and outcome of bilirubin encephalopathy in Nigeria: a bi-centre study. Niger J Med 2007;16:354-9. DOI: https://doi.org/10.4314/njm.v16i4.37337
Adebami OJ. Factors associated with the incidence of acute bilirubin encephalopathy in Nigerian population. J Ped Neurol 2011;9:347-53. DOI: https://doi.org/10.3233/JPN-2011-0485
Owa JA, Ogunlesi TA. Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria. World J Pediatr 2009;5:51-5. DOI: https://doi.org/10.1007/s12519-009-0009-2
Bhutani VK, Wong RJ. Bilirubin neurotoxicity in preterm infants: risk and prevention. J Clin Neonatol 2013;2:61–9. DOI: https://doi.org/10.4103/2249-4847.116402
Tan KL. Phototherapy for neonatal jaundice. Acta Paediatr 1996;85:277-9. DOI: https://doi.org/10.1111/j.1651-2227.1996.tb14014.x
World Health Organization. Interagency list of priority medical devices for essential interventions for reproductive, maternal, newborn and child health. Available from: http://www.who.int/ medical_devices/ md_maternal_BOOK_May201 6_D.pdf
Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice. N Engl J Med 2008;358:920–8. DOI: https://doi.org/10.1056/NEJMct0708376
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114:297–316. DOI: https://doi.org/10.1542/peds.114.1.297
UNICEF. Phototherapy Light – Jaundice Management, UNICEF November 2022. Available from: phototherapy%20%20services/phototherapy-light-TPP.pdf
Olusanya BO, Osibanjo FB, Mabogunje CA, et al. The burden and management of neonatal jaundice in Nigeria: A scoping review of the literature. Niger J Clin Pract 2016;19:1-17 DOI: https://doi.org/10.4103/1119-3077.173703
Moyer VA, Ahn C, Sneed S. Accuracy of Clinical Judgment in Neonatal Jaundice. Arch Pediatr Adolesc Med 2000;154:391–4. DOI: https://doi.org/10.1001/archpedi.154.4.391
WHO. Interagency list of priority medical devices for essential interventions for reproductive, maternal, newborn and child health. Available from: http://www.who.int/ medical_devices/ md_maternal_BOOK_May201 6_D.pdf
Ekwochi U, Osuorah CD, Ndu IK. Determinants of delay in presentation and clinico-laboratory features of newborns admitted for neonatal jaundice in a tertiary hospital in south-east Nigeria. J Med Trop 2018;20:128-34 DOI: https://doi.org/10.4103/jomt.jomt_21_18
Abdulkadir I, Adebiyi NM, Adeoye G, Ogala WN. An evaluation of phototherapy services in newborn units in Kaduna State Nigeria. Niger J Paediatr 2018;45:76-80.
Toma BO, Diala UM, Ofakunrin AOD, et al. Availability and distribution of phototherapy services and healthcare providers for neonatal jaundice in three local government areas in Jos, North - Central Nigeria. Niger J Paediatr 2018;45:1–5. DOI: https://doi.org/10.4314/njp.v45i1.1
Kumar P, Chawla D, Deorari A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database of Systematic Reviews, 2011;2011:CD007969. DOI: https://doi.org/10.1002/14651858.CD007969.pub2
Morris BH, Tyson JE, Stevenson DK, et al. Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: Multi-center observational study. J Perinatol 2013;33:126-33. DOI: https://doi.org/10.1038/jp.2012.39
Eggert P, Stick C, Schröde H. On the distribution of irradiation intensity in phototherapy: Measurements of effective irradiance in an incubator. European J Pediatr 1984; 142:58-61. DOI: https://doi.org/10.1007/BF00442593
Borden AR, Satrom KM, Wratkowski P, et al. Variation in the Phototherapy Practices and Irradiance of Devices in a Major Metropolitan Area. Neonatology 2018;113:269-74. DOI: https://doi.org/10.1159/000485369
Maisels MJ. Managing the jaundiced newborn: a persistent challenge. CMAJ 2015;187:335-43. DOI: https://doi.org/10.1503/cmaj.122117

Supporting Agencies

None

How to Cite

Ezeudu, C. E., Osuorah, C. D., Iloh, O. N., Iloh , K. K., Onukwuli, V. O., Igbokwe , O. O., … Udeogu , K. E. (2022). Phototherapy services for newborns with jaundice: Availability and practices in Southeast Nigeria. Annals of Clinical and Biomedical Research, 3(3). https://doi.org/10.4081/acbr.2022.240